Association of hypertension with coexistence of abnormal metabolism and inflammation and endothelial dysfunction

References

• Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens. 2001;19:857–861.
   PubMed Web of Science ®Google Scholar
• Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens. 2003;16:429–433.
   PubMed Web of Science ®Google Scholar
• Gupta V, Sachdeva S, Khan AS, Haque SF. Endothelial dysfunction and inflammation in different stages of essential hypertension. Saudi J Kidney Dis Transpl. 2011;22:97–103.
   PubMedGoogle Scholar
• Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, et al. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132–140.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran N, Amalraj E, Datta M, Krishnamurthy PV, Sankaran JR, Rajasambandam P. Association between obesity and hypertension in south Indian patients. Indian Heart J. 1994;46:21–24.
   PubMedGoogle Scholar
• Zhang M, Batu B, Tong W, Liu YY, Liu Y, Zhang Y. Clustering of hyperlipidemia, hyperglycemia, alcohol drinking, overweight and central obesity and hypertension in Mongolian people, China. CVD Prev Control. 2009;4:163–169.
   Google Scholar
• Gus M, Fuchs SC, Moreira LB, Moraes RS, Wiehe M, Silva AF, et al. Association between different measurements of obesity and the incidence of hypertension. Am J Hypertens. 2004;17:50–53.
   PubMed Web of Science ®Google Scholar
• Guo ZR, Hu XS, Wu M, Zhou MH, Zhou ZY. [A prospective study on the association between dyslipidemia and hypertension]. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30: 554–558.
   PubMedGoogle Scholar
• Bonaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromso Study. Circulation. 1991;83:1305–1314.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Buring JE, Chown MJ, Ridker PM, Gaziano JM. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med. 2005;165:2420–2427.
   PubMedGoogle Scholar
• Movahed MR, Sattur S, Hashemzadeh M. Independent association between type 2 diabetes mellitus and hypertension over a period of 10 years in a large inpatient population. Clin Exp Hypertens. 2010;32:198–201.
   PubMed Web of Science ®Google Scholar
• Miyao M, Furuta M, Kondo T, Sakakibara H, Ishihara S, Yamanaka K, Yamada S. The relationship of high-density lipoprotein cholesterol to obesity, drinking and smoking habits. Nagoya J Med Sci 1993;55:65–70.
   PubMedGoogle Scholar
• Pacholczyk M, Ferenc T, Kowalski J. The metabolic syndrome. Part I: Definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk. Postepy Hig Med Dosw (Online) 2008;62:530–542.
   PubMedGoogle Scholar
• Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972–978.
   PubMed Web of Science ®Google Scholar
• Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 2003;166:387–394.
   PubMed Web of Science ®Google Scholar
• Hossain M, Faruque MO, Kabir G, Hassan N, Sikdar D, Nahar Q, et al. Association of serum TNF-α and IL-6 with insulin secretion and insulin resistance in IFG and IGT subjects in a Bangladeshi population. Int J Diabetes Mellitus. 2010;2:165–168.
   Google Scholar
• Zhang M, Batu B, Tong W, Li H, Lin Z, Li Y, et al. Prehypertension and cardiovascular risk factor clustering among Mongolian population in rural and animal husbandry area, Inner Mongolia, China. Circ J. 2009;73:1437–1441.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752.
   PubMed Web of Science ®Google Scholar
• Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103:398–406.
   PubMed Web of Science ®Google Scholar
• Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation. 2003;108:1917–1923.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342: 836–843.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Touyz RM. Multiple actions of angiotensin II in hypertension: Benefits of AT1 receptor blockade. J Am Coll Cardiol. 2003;42:911–913.
   PubMedGoogle Scholar
• Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, et al. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation. 1999;100:1646–1652.
   PubMed Web of Science ®Google Scholar
• Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis. 2009;205:290–295.
   PubMed Web of Science ®Google Scholar
• Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129–2138.
   PubMed Web of Science ®Google Scholar
• Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.[see comment]. Diabetes Care. 2002;25:2016–2021.
   PubMed Web of Science ®Google Scholar
• Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–419.
   PubMed Web of Science ®Google Scholar
• Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97: 3A–11A.
   PubMed Web of Science ®Google Scholar
• Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Festa A, D’Agostino R, Jr., Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–47.
   PubMed Web of Science ®Google Scholar
• Kraja AT, Province MA, Arnett D, Wagenknecht L, Tang W, Hopkins PN, et al. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond). 2007;4:28.
   PubMedGoogle Scholar
• Park K, Steffes M, Lee DH, Himes JH, Jacobs DR, Jr.Association of inflammation with worsening HOMA-insulin resistance. Diabetologia. 2009;52:2337–2344.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–1801.
   PubMed Web of Science ®Google Scholar
• Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep. 2003;3:279–288.
   PubMedGoogle Scholar